Table 3.
Rates of endoscopic and clinical recurrence.
| Low-risk patients | High-risk patients | |||||
|---|---|---|---|---|---|---|
| Prophylactic n = 11 | Endoscopy-guided n = 44 | p-value | Prophylactic n = 37 | Endoscopy-guided n = 111 | p-value | |
| Endoscopic recurrence, n [%] | 4 [36.4] | 18 [40.9] | 0.78 | 9 [24.3] | 49 [44.5] | 0.03 |
| Modified Rutgeerts score, n [%] | 0.36 | 0.23 | ||||
| i0 | 2 [18.2] | 12 [27.3] | 12 [32.4] | 21 [19.1] | ||
| i1 | 3 [27.3] | 6 [13.6] | 4 [10.8] | 15 [13.6] | ||
| i2a | 2 [18.2] | 8 [18.2] | 12[32.4] | 25 [22.7] | ||
| i2b | 1 [9.1] | 12 [27.3] | 6 [16.2] | 27 [24.5] | ||
| i3 | - | 2 [4.5] | 1 [2.7] | 12 [10.9] | ||
| i4 | 3 [27.3] | 4 [9.4] | 2 [5.4] | 10 [9.1] | ||
| Clinical recurrence, n [%] | ||||||
| 1 year | 3 [27.3] | 13 [29.5] | 0.73 | 9 [24.3] | 34 [30.6] | 0.19 |
| 2 years | 5 [45.4] | 16 [36.4] | 0.22 | 14 [37.8] | 46 [41.4] | 0.19 |
| 3 years | 5 [45.4] | 19 [43.2] | 0.94 | 20 [54.1] | 54 [48.6] | 0.43 |
Values in bold are significant.